Document is current
Any future updates will be listed below
-
Authors
Reuvekamp, Tom https://orcid.org/0009-0001-1346-6606
Ngai, Lok Lam https://orcid.org/0000-0003-0969-3766
den Hartog, Daphne
Carbaat-Ham, Jannemieke
Fayed, Mona M. H. E.
Scholten, Willemijn J.
Mocking, Tim R. https://orcid.org/0000-0001-9170-4131
Chitu, Dana A.
Pabst, Thomas https://orcid.org/0000-0002-6055-5257
Klein, Saskia K. https://orcid.org/0000-0001-8847-2704
Stussi, Georg https://orcid.org/0000-0002-1667-0637
Griskevicius, Laimonas
Breems, Dimitri
van Lammeren-Venema, Danielle
Boersma, Rinske
Ossenkoppele, Gert J.
van de Loosdrecht, Arjan A. https://orcid.org/0000-0001-8311-983X
Bachas, Costa https://orcid.org/0000-0001-5983-6193
Huls, Gerwin
de Leeuw, David C.
Cloos, Jacqueline https://orcid.org/0000-0001-9150-8026
-
Funding
Funding for this research was provided by:
Amsterdam UMC MD/PhD Grant
- License Information
-
More Information
Article History
Received: 9 November 2024
Revised: 25 January 2025
Accepted: 11 February 2025
First Online: 27 February 2025
Competing interests
: LG holds membership on an entity’s board of directors or advisory committees for Miltenyi Biomedicine. AAvdL has received honoraria from Amgen, Novartis, Celgene/BMS, and Takeda and has received research funding from Alexion. DCdL participates in the sponsored speaker’s bureau of Servier, Roche and AbbVie; is part of the scientific advisory board of Takeda and Servier. GJO serves as a consultant for Novartis, Pfizer Inc, Celgene, Janssen, AGIOS, Amgen, Gilead, Astellas, Roche, Jazz Pharmaceuticals, and Merus; has received honoraria from Novartis, Celgene, AGIOS, Gilead, and Astellas; received research funding from Novartis; and holds membership on an entity’s board of directors for Roche. JC receives royalties from Navigate and BD Biosciences; participated in the sponsored speaker’s bureau of Astellas; and has received research funding from Takeda, DC-one, Genentech, Janssen, Novartis, and Merus. The remaining authors declare no competing financial interests.
: Patients signed informed consent and the study was conducted according to the declaration of Helsinki. The study was approved by the medical ethics committee of the University Medical Center Groningen (number: 2015.550).
